76 results on '"Voss, F."'
Search Results
2. Human Myocardial Mitochondrial Function is Impaired in Cardiac Light Chain Amyloidosis but Not in Transthyretin Amyloidosis
3. Effect of Cytomegalovirus Prophylaxis with Immunoglobulins or Antiviral Drugs on Lymphoproliferative Disease After Heart Transplantation: Single-Center Experience in 300 Patients
4. Heart Transplantation in Patients on Temporary Mechanical Circulatory Support
5. Anthracycline therapy induces an early decline of cardiac contractility with transient edema in low risk patients with breast cancer
6. Validating available Donor-recipient risk assessment tools in a German Heart Transplant cohort
7. Impact of fast tacrolimus metabolizer status on outcome after heart transplantation
8. German Cardiac Arrest Registry (G-CAR): results of the pilot phase
9. De Novo Malignancies after Heart Transplantation—A Single Center Experience.
10. POS1329 DESIGN OF A PHASE III, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
11. Gender-specific differences in young patients receiving implantable cardioverter-defibrillator therapy - a subgroup analysis of the german device registry
12. (656) Assessment of Risk Factors for Cytomegalovirus DNAemia after Termination of Regular Prophylaxes after Heart Transplantation
13. Impact of SARS-CoV-2 Infection on Reactivation of Herpesviridae after Heart and Heart and Kidney Transplantation
14. Subclinical Myocardial Leukocyte Infiltration after Covid-19-Vaccination in Heart-Transplant Recipients
15. Safety and Efficacy of BI 1015550, a Preferential Inhibitor of Phosphodiesterase 4B, in Patients with Idiopathic Pulmonary Fibrosis: a Phase 2 Trial*
16. Sécurité d’emploi et efficacité de Bl 1015550, un inhibiteur préférentiel de la phosphodiestérase 4B (PDE4Bi), chez des patients atteints de fibrose pulmonaire idiopathique : essai de phase II
17. Subclinical Myocardial Leukocyte Infiltration after COVID-19 Vaccination in Heart-Transplant Recipients
18. 10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic.
19. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
20. Procedure related complications following implantation of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) devices - Insights from the German DEVICE registry
21. Decline in forced vital capacity as a surrogate for mortality in patients with fibrosing interstitial lung diseases*
22. Safety and Efficacy of BI 1015550, a Preferential Inhibitor of Phosphodiesterase 4b, in Patients with Idiopathic Pulmonary Fibrosis: A Phase 2 Trial
23. (510) - Effect of Cytomegalovirus Prophylaxis with Immunoglobulins or Antiviral Drugs on Lymphoproliferative Disease After Heart Transplantation: Single-Center Experience in 300 Patients
24. Minimally Invasive Surgical Ablation Combined with Postoperative Electrophysiological Evaluation and Intervention Is Highly Effective in the Treatment of Intermittent and Long-Standing Atrial Fibrillation
25. (650) Impact of SARS-CoV-2 Infection on Reactivation of Herpesviridae after Heart and Heart and Kidney Transplantation
26. (417) Subclinical Myocardial Leukocyte Infiltration after Covid-19-Vaccination in Heart-Transplant Recipients
27. (374) - Human Myocardial Mitochondrial Function is Impaired in Cardiac Light Chain Amyloidosis but Not in Transthyretin Amyloidosis.
28. Früh postoperative pulmonalvenöse Stauung nach Herztransplantation: Wird das Outcome beeinflusst?
29. DESIGN OF A PHASE III, RANDOMISED, PLACEBOCONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE.
30. (510) - Effect of Cytomegalovirus Prophylaxis with Immunoglobulins or Antiviral Drugs on Lymphoproliferative Disease After Heart Transplantation: Single-Center Experience in 300 Patients.
31. Assessment of Risk Factors for Cytomegalovirus DNAemia after Termination of Regular Prophylaxes after Heart Transplantation.
32. Anthracycline therapy induces an early decline of cardiac contractility in low-risk patients with breast cancer.
33. Amiodarone Administration during Cardiopulmonary Resuscitation Is Not Associated with Changes in Short-Term Mortality or Neurological Outcomes in Cardiac Arrest Patients with Shockable Rhythms.
34. German Cardiac Arrest Registry (G-CAR)-results of the pilot phase.
35. Myocardial Mitochondrial Function Is Impaired in Cardiac Light-Chain Amyloidosis Compared to Transthyretin Amyloidosis.
36. Serological profiling of pneumococcal proteins reveals unique patterns of acquisition, maintenance and waning of antibodies throughout life.
37. Lipidation of pneumococcal proteins enables activation of human antigen-presenting cells and initiation of an adaptive immune response.
38. Estimating the effect of nintedanib on forced vital capacity in children and adolescents with fibrosing interstitial lung disease using a Bayesian dynamic borrowing approach.
39. Outcome of Patients Managed by Percutaneous Left Ventricular Assist Device Implantation During On-Hours and Off-Hours.
40. Off-label: The results of adjunctive bone morphogenetic protein for challenging femur fractures; a review of two cases.
41. Accredited cardiac arrest centers facilitate eCPR and improve neurological outcome.
42. Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis.
43. Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation.
44. Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).
45. Cocoa flavanols improve peakVO 2 and exercise capacity in a randomized double blinded clinical trial in healthy elderly people.
46. A Physical Phantom for the Simulation of Neonatal Thermoregulation.
47. Lactate versus Phosphate as Biomarkers to Aid Mechanical Circulatory Support Decisions in Patients with Out-of-Hospital Cardiac Arrest and Return of Spontaneous Circulation.
48. Multi-modal body part segmentation of infants using deep learning.
49. [Anticoagulation after heart valve replacement].
50. Elevated Initial Serum Phosphate Levels Predict Higher Mortality and Impaired Neurological Outcome in Cardiac Arrest Patients with Return of Spontaneous Circulation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.